Interim's Sept 423 Aug 2017 11:54
23 August 2017
AIM: AMYT
ESM: AYP
Amryt Pharma plc
Notice of Interim Results
Amryt Pharma, the biopharmaceutical company focused on innovative therapies for patients with rare and orphan diseases, will announce interim results, covering the six months to 30 June 2017, on Monday, 4 September 2017